Scovern Law Reports Over 18,000 Xarelto Cases Filed as Second Bellwether Trial Set to Get Underway

Posted on Posted in Xarelto

SAN FRANCISCO, May 24, 2017 — Xarelto patients who suffered internal bleeding and other life-threatening complications allegedly related to use of the medication continue to file lawsuits in courts throughout the U.S. According to a May 3rd filing with the U.S. Securities and Exchange Commission, Johnson & Johnson and Bayer AG have been named defendants […]

Bayer, Janssen Score Win In 1st Xarelto Trial

Posted on Posted in Xarelto

(May 4, 2017) – A Louisiana federal jury on Wednesday sided with Janssen and Bayer in the first bellwether trial in multidistrict litigation over unstoppable bleeding allegedly caused by their blood thinner Xarelto. The jury found in favor of Johnson & Johnson unit Janssen Pharmaceuticals Inc. and Bayer HealthCare Pharmaceuticals Inc. in the first of […]